Page last updated: December 2025

The information on this webpage was adapted from Understanding Melanoma - A guide for people with cancer, their families and friends (2025 edition). This webpage was last updated in December 2025.

Expert content reviewers:

This information is based on Australian clinical practice guidelines, and was developed with the help of a range of health professionals and people affected by melanoma:

  • A/Prof Rachel Roberts-Thomson, Medical Oncologist, The Queen Elizabeth Hospital, SA
  • A/Prof Robyn Saw, Surgical Oncologist, Melanoma Institute Australia, Royal Prince Alfred Hospital and The University of Sydney, NSW
  • Alison Button-Sloan, Consumer
  • Dr Marcus Cheng, Radiation Oncologist Registrar, Alfred Health, VIC
  • Prof Anne Cust, Deputy Director, The Daffodil Centre, The University of Sydney and Cancer Council NSW, Chair, National Skin Cancer Committee, Cancer Council, and faculty member, Melanoma Institute Australia
  • Prof David Gyorki, Surgical Oncologist, Peter MacCallum Cancer Centre, VIC
  • Dr Rhonda Harvey, Mohs Surgeon, Dermatologist, Green Square Dermatology, The Skin Hospital, Darlinghurst and Sydney Melanoma Diagnostic Centre, RPA, NSW
  • David Hoffman, Consumer
  • A/Prof Jeremy Hudson, Southern Cross University, James Cook University, Chair of Dermatology RACGP, Clinical Director, North Queensland Skin Cancer, QLD
  • Dr Damien Kee, Medical Oncologist, Austin Health and Peter MacCallum Cancer Centre and Clinical Research Fellow, Walter & Eliza Hall Institute, VIC
  • Angelica Miller, Melanoma Community Support Nurse, Melanoma Institute Australia, WA
  • Romy Pham, 13 11 20 Consultant, QLD
  • A/Prof Sasha Senthi, Radiation Oncologist, Alfred Health, and Clinical Research Fellow, Victorian Cancer Agency, VIC
  • Dr Chistoph Sinz, Dermatologist, Melanoma Institute Australia, NSW
  • Dr Amelia Smit, Research Fellow, Melanoma and Skin Cancer, The Daffodil Centre, The University of Sydney and Cancer Council NSW
  • Nicole Taylor, Clinical Nurse Consultant, Crown Princess Mary Cancer Centre, Westmead Hospital, NSW

When melanoma has spread to distant lymph nodes, internal organs or bones (stage 4), it is known as advanced or metastatic melanoma.

Treatment may include immunotherapy, targeted therapy, radiation therapy and surgery. Palliative treatment may also be offered to help manage symptoms and improve quality of life.

Since more effective treatments are now available, chemotherapy is rarely used to treat melanoma. You will be offered a treatment plan based on factors such as the features of the melanoma, where it has spread and any symptoms you have.

New developments are occurring all the time, and you may be able to get new treatments through clinical trials. For support and information, call Cancer Council 13 11 20.

Your guide to best cancer care

A lot can happen in a hurry when you’re diagnosed with cancer.

The  guide to best cancer care for melanoma can help you make sense of what should happen. It will help you with what questions to ask your health professionals to make sure you receive the best care at every step.

Read the guide

Immunotherapy

Immunotherapy drugs called checkpoint inhibitors use the body’s own immune system to fight cancer. Checkpoint inhibitors remove barriers that stop the immune system from finding and attacking cancer.

Checkpoint inhibitors used for advanced melanoma include relatlimab, ipilimumab, nivolumab and pembrolizumab. Sometimes more than one drug is used, with different combinations working for different people.

How it works

You will usually have immunotherapy as an outpatient, which means you visit a treatment centre for the day. In most cases, the immunotherapy drugs are given into a vein (intravenously).

You may have treatment every 2–6 weeks in a repeating cycle for up to two years, but this depends on how the melanoma responds to the drugs and any side effects you may have.

Immunotherapy using checkpoint inhibitors has worked well for some people with melanoma, but it does not help everyone.

While most people treated with checkpoint inhibitors have had advanced cancer, immunotherapy is now available for some people with earlier stage melanoma.

Other immunotherapy treatments are being tested in clinical trials. Talk to your doctor about whether immunotherapy is an option for you.

Checkpoint inhibitors can take weeks or months to start working, depending on how your immune system and the cancer respond. Sometimes their effects keep working long after treatment stops, but this varies from person to person.

Other times cancer cells can become resistant to the treatment even if it works at first.

Possible side effects of immunotherapy

The side effects of immunotherapy drugs will vary depending on which drugs you are given and can be unpredictable.

Immunotherapy can cause inflammation in any of the organs in the body, which can lead to side effects such as tiredness, joint pain, diarrhoea, and an itchy rash or other skin problems.

The inflammation can lead to more serious side effects in some people, and in rare cases, this can be life threatening, but these side effects will be monitored closely and managed quickly.

You may have side effects within days of starting immunotherapy, but more often they occur many weeks or months later. It is important to discuss any side effects with your treatment team as soon as they appear so they can be managed appropriately.

When side effects are treated early, they are likely to be less severe and last for a shorter time. Delaying or stopping treatment for a side effect does not mean immunotherapy will stop working.

Many patients stop treatment after only one or a few treatments and their melanoma remains controlled years later without further treatment.

 

Targeted therapy

Targeted therapy is a drug treatment that targets specific features of cancer cells to stop the cancer growing and spreading. Your doctor will check if the melanoma you have has a specific mutation before offering you a targeted therapy drug.

About 50% of people with melanoma have a BRAF mutation. This mutation can be blocked by giving BRAF and MEK inhibitor drugs – a treatment shown to be effective for people with advanced melanoma that has the BRAF mutation.

Targeted therapy drugs are generally taken as tablets (orally) once or twice a day, often for many months or even years. A good response from targeted therapy will make cancer that can be seen on a scan shrink or even disappear completely on scans.

In some cases, the cancer remains stable, which means it doesn’t grow in size. Cancer cells can sometimes become resistant to targeted therapy drugs over time. If this happens, your doctor may suggest trying another type of treatment.

Possible side effects of targeted therapy

The side effects of targeted therapy will vary depending on which drugs you are given. Common side effects include fever, tiredness, joint pain, rash and other skin problems, loss of appetite, nausea and diarrhoea.

Ask your treatment team how you can deal with any side effects.

 

Radiation therapy

Also known as radiotherapy, radiation therapy is the use of targeted radiation to kill or damage cancer cells. Radiation therapy may be offered on its own or with other treatments.

It can be used after surgery to stop melanoma coming back. It can also be used to help relieve pain and other symptoms caused by melanoma that has spread – for example, to the brain or bone (palliative treatment).

How it works

Before starting treatment, you will have a CT or MRI scan at a planning appointment. The radiation therapist may make some small permanent or temporary marks (tattoos) on your skin so that the same area is targeted during each treatment session.

If you are having radiation therapy to the brain, a plastic mask will be custom-made to fit you. It helps keep your head still so that the radiation is targeted at the same area each session.

Each treatment session takes about 30 minutes and is usually given daily for 1–4 weeks. For the treatment, you will lie on a table under a machine that aims radiation at the affected part of your body.

In some cases, you may be offered a specialised type of radiation therapy that delivers extremely precise, tightly focused beams of high-dose radiation onto the tumour from many different angles.

This is called stereotactic radiosurgery (SRS) when used on the brain, and stereotactic body radiation therapy (SBRT) when used on other parts of the body. SBRT usually involves 3–5 treatment sessions over 1–2 weeks.

Side effects of radiation therapy

The side effects that you experience will depend on the part of the body that receives radiation therapy, the dose of radiation you receive and how long you have treatment. Many people will have temporary side effects, which may build up over time.

Common side effects during or immediately after radiation therapy include tiredness, and the skin in the treatment area becoming red and sore. Ask your treatment team for advice about dealing with any side effects.

Surgery

In some cases, surgery may be recommended for people with advanced melanoma. It is used to remove melanoma from the skin, lymph nodes, or other organs such as the lung, bowel or brain.

Your suitability for surgery will be discussed at a multidisciplinary team meeting. Talk to your treatment team about what the surgery involves and what recovery will be like.

Side effects will depend on the type of surgery, but often include pain and risk of infection.

Learn more

Palliative treatment

In some cases of advanced melanoma, the treatment team may talk to you about palliative treatment. Palliative treatment aims to improve people’s quality of life by managing the symptoms of cancer without trying to cure the disease.

It can be used at any stage of advanced cancer and does not mean giving up hope. Some people have palliative treatment as well as active treatment of the melanoma.

When used as palliative treatment, radiation therapy and medicines can help manage symptoms caused by advanced melanoma, such as pain, nausea and shortness of breath.

Palliative treatment is one aspect of palliative care, in which a team of health professionals aims to meet your physical, emotional, cultural, social and spiritual needs. The team also supports families and carers.

Advanced melanoma clinical trials

Cancer clinical trials are research studies that test whether a new approach to prevention, screening, diagnosis, or treatment works better than current methods and is safe.

There are clinical trials for advanced melanoma open to recruitment in Victoria. This list shows the most recently updated advanced melanoma studies on the Victorian Cancer Trials Link (VCTL).

Visit the VCTL to find more advanced melanoma clinical trials.

 

Understanding Melanoma

Download our Understanding Melanoma booklet to learn more.

Download now   Order for free